Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lloydspharmacy Antiseptic Throat lozenges
1203030A0BIAAAC
|
Lloydspharmacy (Amylmetacresol) | Amylmetacresol | Ear, Nose and Oropharynx | No data available |
|
Lloydspharmacy Double Action Throat Blackcurrant 2.4mg loz
1203030J0BHAAAA
|
Lloydspharmacy (Hexylresorcinol) | Hexylresorcinol | Ear, Nose and Oropharynx | No data available |
|
Lloydspharmacy Sugar Free Antiseptic 250microgram lozenges
1203030F0BEAAAC
|
Lloydspharmacy (Dequalinium) | Dequalinium chloride | Ear, Nose and Oropharynx | No data available |
|
Locabiotal 500micrograms/dose nasal/oromucosal spray
1202030D0BBABAB
|
Locabiotal | Fusafungine | Ear, Nose and Oropharynx | No data available |
|
Loramyc 50mg muco-adhesive buccal tablets
1203020H0BDAAAD
|
Loramyc | Miconazole | Ear, Nose and Oropharynx | No data available |
|
Lozamine 3mg lozenges
1203030Y0BBAAAA
|
Lozamine | Benzydamine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Luborant spray
1203050A0BCAAAF
|
Luborant | Artificial saliva products | Ear, Nose and Oropharynx | No data available |
|
Medijel pastilles
1203030M0BBABAF
|
Medijel (Pastilles) | Lidocaine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Meggezones 16mg pastilles
1203030N0BFAAA0
|
Meggezones | Menthol | Ear, Nose and Oropharynx | No data available |
|
Menthol 0.14% / Eucalyptus oil 0.028% lozenges
1203030N0AAAKAK
|
Menthol | Menthol | Ear, Nose and Oropharynx | No data available |
|
Menthol 0.16% / Eucalyptus oil 0.14% lozenges sugar free
1203030N0AAAJAJ
|
Menthol | Menthol | Ear, Nose and Oropharynx | No data available |
|
Menthol 0.185% / Eucalyptus oil 0.08% lozenges
1203030N0AAAGAG
|
Menthol | Menthol | Ear, Nose and Oropharynx | No data available |
|
Menthol 0.24% / Eucalyptus oil 0.1% lozenges sugar free
1203030N0AAAHAH
|
Menthol | Menthol | Ear, Nose and Oropharynx | No data available |
|
Menthol 0.3% / Anise oil 0.2% lozenges
120303000AAAHAH
|
Generic compound preparation BNF 1203030 | Other lozenge and spray preparations | Ear, Nose and Oropharynx | No data available |
|
Menthol 0.52% / Eucalyptus oil 0.26% lozenges
1203030N0AAAIAI
|
Menthol | Menthol | Ear, Nose and Oropharynx | No data available |
|
Menthol 8mg/g / Eucalyptus oil 6mg/g pastilles
1203030N0AAADAD
|
Menthol | Menthol | Ear, Nose and Oropharynx | No data available |
|
Merocaine lozenges
1203030B0BNAAAH
|
Merocaine | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Merocets 1.4mg lozenges
1203030D0BBAAAA
|
Merocets | Cetylpyridinium chloride | Ear, Nose and Oropharynx | No data available |
|
Merocets Plus lozenges
1203030D0BFAAA0
|
Merocets Plus | Cetylpyridinium chloride | Ear, Nose and Oropharynx | No data available |
|
Metronidazole 25% oromucosal gel sugar free
1203020J0AAAAAA
|
Metronidazole (Mouthwash) | Metronidazole | Ear, Nose and Oropharynx | No data available |
|
Miconazole 50mg muco-adhesive buccal tablets sugar free
1203020H0AAADAD
|
Miconazole (Mouthwash) | Miconazole | Ear, Nose and Oropharynx | No data available |
|
Minocycline 2% dental gel sugar free
1203020P0AAAAAA
|
Minocycline hydrochloride (Mouthwash) | Minocycline hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Neo-Cortef ear/eye drops
1201010G0BBAAAA
|
Neo-Cortef (Ear/Eye) | Hydrocortisone acetate | Ear, Nose and Oropharynx | No data available |
|
Neo-Cortef ear/eye ointment
1201010G0BBABAB
|
Neo-Cortef (Ear/Eye) | Hydrocortisone acetate | Ear, Nose and Oropharynx | No data available |
|
Neomycin 0.35% / Triamcinolone 0.1% ear drops
1201010Z0AAABAB
|
Triamcinolone acetonide (Ear) | Triamcinolone acetonide | Ear, Nose and Oropharynx | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.